Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2025 Earnings Call Transcript May 12, 2025
Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, expectations were $-0.31.
Operator: Good day and thank you for standing by. Welcome to the Coherus BioSciences First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]...
